BHB-1893

Asset

Cardiac myosin inhibitor that reduces myocardial hypercontractility

Stage: Phase 3
Modality: Small molecule
Target: MYH7; 1
Indication: 1
Trial: 1
Developer

Indications

1

Hypertrophic obstructive cardiomyopathy
Phase 3, Recruiting, NCT07755904, clinicaltrials.gov, 7 Oct 2026

In the full profile

Targets and what it contains1
Owner and partners1
Trials1
Evidence for its targets1
Competitors5
Signals1

Every asset’s record: target, stage, trials and the evidence behind it.